Annual report pursuant to Section 13 and 15(d)

Fair Value Measurements (Tables)

v3.23.1
Fair Value Measurements (Tables)
12 Months Ended
Dec. 31, 2022
Fair Value Disclosures [Abstract]  
Schedule of Changes in Fair Value of Level 3 Valued Instruments

The following tables present changes in fair value of level 3 valued instruments as of and for the years ended December 31, 2022 and 2021:

 

    vivoPharm Business  
Balance - January 1, 2022   $ 11,000  
Additions     -  
Measurement adjustments     (5,528 )
Sale of vivoPharm businesses     (5,472 )
Balance - December 31, 2022   $ -  

 

The following tables present changes in fair value of level 3 valued instruments for the year ended December 31, 2021:

 

    2020 Convertible Note     Warrant     Embedded Derivative     vivoPharm Business  
Balance - January 1, 2021   $ -     $ -     $ 1,690     $ -  
Additions     3,746       635       325       11,000  
Measurement adjustments     4       (214 )     250       -  
Settlement     (3,750 )     (421 )     (2,265 )     -  
Balance - December 31, 2021   $ -     $ -     $ -     $ 11,000